Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2/3 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 15Breast 14Gastrointestinal 13Head & Neck 6Endocrine 6Thoracic 5Genitourinary 5Tumor-Agnostic 3Other 2Sarcoma 1Other solid neoplasm 1Other neoplasm 1

Conditions

Neoplasms 3

Interventions

pembrolizumab 94Paclitaxel 85Gemcitabine 83Carboplatin 79Docetaxel 60Cisplatin 58Bevacizumab 58Nivolumab 56Fluorouracil 47Capecitabine 46Magnetic Resonance Spectroscopy 44Radiotherapy 41Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 37Pemetrexed 34Leucovorin 34Biopsy 34atezolizumab 33Cetuximab 32Standard of Care 31Trastuzumab 28Cyclophosphamide 28Radiosurgery 27Blood Specimen Collection 27Specimen Handling 26Sorafenib 26Ipilimumab 26Everolimus 26olaparib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Dexmedetomidine × Tumor-Agnostic × Clear all
NCT06409104 2024-05-14

Propofol Versus Dexmedetomidine for Sedation of Cancer Patients Undergoing ERCP

National Cancer Institute, Egypt

Phase NA Completed
202 enrolled
Tumor-Agnostic

Neoplasms

NCT05636566 2022-12-05

Comparing TIVA Using Propofol or Dexmedetomidine Versus Sevoflurane During Anaesthesia of Children Undergoing Bone-Marrow Aspiration

Alexandria University

Phase 2/3 Completed
60 enrolled
Tumor-Agnostic

Neoplasms

NCT02641938 2018-01-02

Effect of Intraoperative Dexmedetomidine on Development of Acute Kidney Injury

Gangnam Severance Hospital

Phase 4 Completed
38 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡